Abstract
Abstract No. 693 CRISPR-based genome editing identifies metabolic dependencies of a biopsy-derived hepatocellular carcinoma cell line, enabling targeted therapy selection and response evaluation
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
